Annual EBIT
-$23.41 M
+$9.16 M+28.12%
December 31, 2023
Summary
- As of February 12, 2025, CRVS annual earnings before interest & taxes is -$23.41 million, with the most recent change of +$9.16 million (+28.12%) on December 31, 2023.
- During the last 3 years, CRVS annual EBIT has risen by +$20.35 million (+46.51%).
- CRVS annual EBIT is now -69.99% below its all-time high of -$13.77 million, reached on December 31, 2015.
Performance
CRVS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$7.25 M
-$1.32 M-22.24%
September 30, 2024
Summary
- As of February 12, 2025, CRVS quarterly earnings before interest & taxes is -$7.25 million, with the most recent change of -$1.32 million (-22.24%) on September 30, 2024.
- Over the past year, CRVS quarterly EBIT has dropped by -$1.70 million (-30.49%).
- CRVS quarterly EBIT is now -163.11% below its all-time high of $11.50 million, reached on December 31, 2015.
Performance
CRVS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$25.09 M
-$1.70 M-7.24%
September 30, 2024
Summary
- As of February 12, 2025, CRVS TTM earnings before interest & taxes is -$25.09 million, with the most recent change of -$1.70 million (-7.24%) on September 30, 2024.
- Over the past year, CRVS TTM EBIT has dropped by -$1.67 million (-7.14%).
- CRVS TTM EBIT is now -755.20% below its all-time high of $3.83 million, reached on December 31, 2015.
Performance
CRVS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRVS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.1% | -30.5% | -7.1% |
| 3 y3 years | +46.5% | -28.0% | +22.9% |
| 5 y5 years | +52.5% | -28.0% | +22.9% |
CRVS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.4% | -56.6% | +41.8% | -8.7% | +34.1% |
| 5 y | 5-year | at high | +52.1% | -56.6% | +45.3% | -8.7% | +49.6% |
| alltime | all time | -70.0% | +58.6% | -163.1% | +55.3% | -755.2% | +55.6% |
Corvus Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.25 M(+22.2%) | -$25.09 M(+7.2%) |
| Jun 2024 | - | -$5.93 M(-5.1%) | -$23.40 M(+1.4%) |
| Mar 2024 | - | -$6.25 M(+10.7%) | -$23.09 M(-1.4%) |
| Dec 2023 | -$23.41 M(-28.1%) | -$5.65 M(+1.6%) | -$23.41 M(-0.1%) |
| Sep 2023 | - | -$5.56 M(-1.1%) | -$23.42 M(-22.8%) |
| Jun 2023 | - | -$5.62 M(-14.5%) | -$30.34 M(-4.4%) |
| Mar 2023 | - | -$6.57 M(+16.0%) | -$31.73 M(-2.6%) |
| Dec 2022 | -$32.56 M(-15.7%) | -$5.67 M(-54.6%) | -$32.56 M(+3.3%) |
| Sep 2022 | - | -$12.47 M(+77.9%) | -$31.53 M(+6.1%) |
| Jun 2022 | - | -$7.01 M(-5.4%) | -$29.72 M(-12.6%) |
| Mar 2022 | - | -$7.41 M(+60.0%) | -$34.00 M(-10.7%) |
| Dec 2021 | -$38.63 M(-11.7%) | -$4.63 M(-56.6%) | -$38.07 M(-12.1%) |
| Sep 2021 | - | -$10.66 M(-5.6%) | -$43.31 M(+1.9%) |
| Jun 2021 | - | -$11.29 M(-1.7%) | -$42.50 M(+1.2%) |
| Mar 2021 | - | -$11.48 M(+16.2%) | -$41.97 M(-4.1%) |
| Dec 2020 | -$43.76 M(-10.4%) | -$9.88 M(+0.3%) | -$43.76 M(-3.4%) |
| Sep 2020 | - | -$9.85 M(-8.6%) | -$45.32 M(-3.5%) |
| Jun 2020 | - | -$10.77 M(-18.9%) | -$46.99 M(-5.7%) |
| Mar 2020 | - | -$13.27 M(+16.0%) | -$49.82 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$48.85 M(-0.7%) | -$11.44 M(-0.6%) | -$48.85 M(+0.6%) |
| Sep 2019 | - | -$11.51 M(-15.3%) | -$48.59 M(+0.8%) |
| Jun 2019 | - | -$13.60 M(+10.5%) | -$48.22 M(+2.9%) |
| Mar 2019 | - | -$12.30 M(+10.2%) | -$46.88 M(-4.8%) |
| Dec 2018 | -$49.22 M(-12.9%) | -$11.17 M(+0.2%) | -$49.22 M(-2.0%) |
| Sep 2018 | - | -$11.15 M(-9.0%) | -$50.24 M(-3.4%) |
| Jun 2018 | - | -$12.26 M(-16.3%) | -$52.03 M(-5.3%) |
| Mar 2018 | - | -$14.64 M(+20.1%) | -$54.95 M(-2.8%) |
| Dec 2017 | -$56.52 M(+52.9%) | -$12.19 M(-5.8%) | -$56.52 M(+1.7%) |
| Sep 2017 | - | -$12.94 M(-14.7%) | -$55.59 M(+4.6%) |
| Jun 2017 | - | -$15.17 M(-6.4%) | -$53.12 M(+13.6%) |
| Mar 2017 | - | -$16.22 M(+44.2%) | -$46.77 M(+26.5%) |
| Dec 2016 | -$36.98 M(+168.5%) | -$11.25 M(+7.4%) | -$36.98 M(+159.8%) |
| Sep 2016 | - | -$10.48 M(+18.7%) | -$14.23 M(+107.0%) |
| Jun 2016 | - | -$8.82 M(+37.3%) | -$6.88 M(+1699.7%) |
| Mar 2016 | - | -$6.43 M(-155.9%) | -$382.00 K(-110.0%) |
| Dec 2015 | -$13.77 M | $11.50 M(-468.5%) | $3.83 M(-150.0%) |
| Sep 2015 | - | -$3.12 M(+33.8%) | -$7.67 M(+68.6%) |
| Jun 2015 | - | -$2.33 M(+5.3%) | -$4.55 M(+105.3%) |
| Mar 2015 | - | -$2.21 M | -$2.21 M |
FAQ
- What is Corvus Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual EBIT year-on-year change?
- What is Corvus Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly EBIT year-on-year change?
- What is Corvus Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM EBIT year-on-year change?
What is Corvus Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CRVS is -$23.41 M
What is the all time high annual EBIT for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual earnings before interest & taxes is -$13.77 M
What is Corvus Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CRVS annual earnings before interest & taxes has changed by +$9.16 M (+28.12%)
What is Corvus Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CRVS is -$7.25 M
What is the all time high quarterly EBIT for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly earnings before interest & taxes is $11.50 M
What is Corvus Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CRVS quarterly earnings before interest & taxes has changed by -$1.70 M (-30.49%)
What is Corvus Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CRVS is -$25.09 M
What is the all time high TTM EBIT for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM earnings before interest & taxes is $3.83 M
What is Corvus Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CRVS TTM earnings before interest & taxes has changed by -$1.67 M (-7.14%)